The invention relates to a composition for use in the treatment or prevention of recognition dysfunction, and/or for improving recognition, in a (prodromal) Alzheimer's patient, in particular in a drug-naive (prodromal) Alzheimer's patient, more particularly in a subject with a mini-mental state examination of 20-30.

The invention relates to a composition for use in the treatment or prevention of recognition dysfunction, and/or for improving recognition, in a (prodromal) Alzheimer's patient, in particular in a drug-naive (prodromal) Alzheimer's patient, more particularly in a subject with a mini-mental state examination of 20-30.

A carbohydrate mixture for dietetic foods and pharmaceuticals is provided. The carbohydrate mixture comprises two different, substantially soluble carbohydrate components A and B, which remain undigested in the gastrointestinal tract and enter the large intestine without being resorbed. Carbohydrate component A may comprise at least one monosaccharide or of at least one oligosaccharide (disaccharide to hexasaccharide) or a mixture of two or more of these saccharides. Carbohydrate component B may comprise a polysaccharide (from heptasaccharide onwards) or a mixture of two or more polysaccharides. Carbohydrate component A=5 to 95 wt-% and carbohydrate component B=5 to 95 wt-% of the sum of the carbohydrate components A+B (=100 wt-%), and at least 80 wt-% of the carbohydrates/saccharides of both carbohydrate components have a prebiotic effect. The carbohydrate mixtures have not only a nutritive effect but they also stimulate health-promoting microorganisms present in the natural flora of the large intestine.

A device receives an ingredient list having a sequence of ingredients ordered by relative amount, and generates formulation vectors by sampling the ingredients list. The device inputs the plurality of formulation vectors into a machine-learned model, the machine-learned model generating an encoded version of each of the plurality of formulation vectors using an encoder, and then outputting a plurality of reconstructed formulation vectors as derived using a decoder. The device identifies reconstructed formulation vectors that have an order that matches the sequence, defines a latent space using the encoded version of the matching reconstructed formulation vectors. The device iteratively samples the latent space until a threshold number of samples are derived that match an ordering constraint that corresponds to the sequence, performs a statistical aggregation of the samples, and outputs an indication of an absolute amount of each ingredient in the ingredients list.

A device receives an ingredient list having a sequence of ingredients ordered by relative amount, and generates formulation vectors by sampling the ingredients list. The device inputs the plurality of formulation vectors into a machine-learned model, the machine-learned model generating an encoded version of each of the plurality of formulation vectors using an encoder, and then outputting a plurality of reconstructed formulation vectors as derived using a decoder. The device identifies reconstructed formulation vectors that have an order that matches the sequence, defines a latent space using the encoded version of the matching reconstructed formulation vectors. The device iteratively samples the latent space until a threshold number of samples are derived that match an ordering constraint that corresponds to the sequence, performs a statistical aggregation of the samples, and outputs an indication of an absolute amount of each ingredient in the ingredients list.

It is an object of the present invention to provide a capsule comprising a functional substance and having good shape stability and a good feeling of use. A method for producing a capsule, comprising steps of mixing gelatin and a functional substance; adding a carbodiimide crosslinking agent to crosslink the gelatin with the carbodiimide crosslinking agent; solidifying the crosslinked gelatin; and grinding the solidified gelatin.

It is an object of the present invention to provide a capsule comprising a functional substance and having good shape stability and a good feeling of use. A method for producing a capsule, comprising steps of mixing gelatin and a functional substance; adding a carbodiimide crosslinking agent to crosslink the gelatin with the carbodiimide crosslinking agent; solidifying the crosslinked gelatin; and grinding the solidified gelatin.

A system and methodology for rehydrating perishable items (e.g., flowers, fresh food items, such as fruits, vegetables, other produce, and nuts) during storage and transportation thereof. The osmotic rehydration apparatus includes a pressurized chamber, a humidifier, an ozone generator, an electrostatic sprayer, a reservoir containing saline, and an air compressor. The perishable items are placed in the osmotic chamber under positive pressure. A film of saline solution is applied to the surface of the perishable items via an electrostatic sprayer. The saline/chlorine film on the perishable items is dried, and the osmotic chamber is saturated with ozone gas via an ozone generator. The osmotic chamber is then saturated with tiny pure water droplets via a humidifier or an electrostatic sprayer. The pressure within the chamber is raised to a pressure above atmospheric pressure. The osmotic chamber is then placed inside a cooler at a temperature slightly above freezing.

A system to create a consumable good utilizing interchangeable ingredients is disclosed in which the system includes an ingredient storage location to hold a plurality of ingredients usable in the consumable good, a selector to gather ingredients selected for inclusion in the consumable good, a mixing device to prepare the ingredients, a processing device to convert the ingredients into the consumable good, and a completion location to at least one of store the consumable good and deliver the consumable good to a user. A method and another system are also disclosed.

A relatively dry, relatively free flowing cannabinoid concentrate composition having a plant extract and a thickening agent. The cannabinoid concentrate composition may have a variety of cannabinoids, drying agents, flowing agents, and/or stabilization agents. The mixture may be a dry powder formulation similar to the consistency of flour or sand. The mixture may comprise a cannabinoid raffinate, an isolated cannabinoid, maltodextrin, and or silica.